Use of semaglutide linked to doubled risk of neovascular macular degeneration - Medical Xpress
12.06.2025 07:42
Semaglutide, widely used to treat diabetes and obesity, was associated with more than double the risk of developing neovascular age-related macular degeneration (nAMD) in older patients with diabetes… [+3834 chars]